Alosetron Tablet
Product Images NDC 63629-2517

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Alosetron (NDC 63629-2517). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

C75cad2b 7d39 4c74 85ff Bff9f1f47a60 01

Chemical structure of Alosetron, illustrating the arrangement of its molecular components including indole and imidazole rings with methyl and hydrochloride groups.*

FDA Label Image

C75cad2b 7d39 4c74 85ff Bff9f1f47a60 02

A bar chart comparing the percent of patients for placebo versus Alosetron Tablets 1 mg given twice daily (B.I.D) across two study groups, Studies 1 & 2 and Studies 3 & 4. The chart shows higher patient percentages for Alosetron in both study groups.*

FDA Label Image

Label (Lbl636292517)

Alosetron Tablets USP, 0.5 mg oral tablet, relabeled by Bryant Ranch Prepack, packaging for 30 tablets. The label includes dosage strength, NDC 63629-2517-1, storage instructions, and dispensing information. BRP Pharmaceuticals logo is displayed on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.